205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.82%
Net income growth under 50% of MCHP's 7.69%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
6.76%
Some D&A expansion while MCHP is negative at -2.93%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-550.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
6.73%
SBC growth well above MCHP's 0.24%. Michael Burry would flag major dilution risk vs. competitor’s approach.
40.90%
Slight usage while MCHP is negative at -104.79%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-538.89%
AR is negative yoy while MCHP is 116.30%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
16.95%
Some inventory rise while MCHP is negative at -92.62%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
159.68%
A yoy AP increase while MCHP is negative at -105.31%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
71.68%
Growth well above MCHP's 134.11%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-177.42%
Negative yoy while MCHP is 7.69%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
20.60%
Some CFO growth while MCHP is negative at -5.62%. John Neff would note a short-term liquidity lead over the competitor.
-47.25%
Negative yoy CapEx while MCHP is 9.52%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-34.32%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-23.87%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
1150.00%
Growth well above MCHP's 35.74%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-8617.86%
We reduce yoy invests while MCHP stands at 14.95%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
64.21%
We repay more while MCHP is negative at -13.01%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-23.53%
Negative yoy issuance while MCHP is 82.09%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
23.30%
We have some buyback growth while MCHP is negative at -26.64%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.